- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03756012
Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation
15. februar 2021 opdateret af: Amol Soin, Kettering Health Network
Multi-Center Evaluation of Clinical Outcomes of Pulse Widths <500 μsec and >1000 μsec During a Temporary Spinal Cord Stimulation Trial
The purpose of this study is to evaluate the effect of pulse widths <500 μsec and >1000 μsec on clinical outcomes during a temporary SCS trial.
Studieoversigt
Status
Afsluttet
Intervention / Behandling
Detaljeret beskrivelse
The proposed study is a prospective, multi-center, two-arm, randomized, crossover design to be conducted at up to 10 sites.
The study will enroll up to 100 subjects in order to include up to 10 subjects in the study per site.
Subjects selected to participate in the trial have back and/or leg pain, have been evaluated as a candidate for SCS and have agreed to undergo a temporary SCS trial using the Algovita® system with percutaneous leads.
Each subject will be followed during the trial period of approximately 7+/-2 days.
The study will end when the last subject has completed the trial period and exited.
The expected enrollment period for this study is approximately six months.
After exit from the clinical study, subjects will continue to be followed by their physician per usual care.
All device and procedure-related AEs will be collected and reported per the study protocol.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
15
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ohio
-
Centerville, Ohio, Forenede Stater, 45458
- The Ohio Pain Clinic
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- be eligible for SCS therapy according to the Algovita® SCS system Indications for Use statement
- be undergoing a SCS trial using Algovita® SCS system
- sign a valid, Institutional Review Board (IRB)-approved informed consent form.
- be 18 years of age or older when written informed consent is obtained
Exclusion Criteria:
- be contraindicated for an Algovita® SCS system
- have a cognitive impairment or exhibits any characteristic, that would limit the study candidate's ability to assess pain relief or complete study assessments
- have a life expectancy of less than 2 years
- be participating in another clinical study that would confound data analysis
- have a coexisting pain condition that might confound pain ratings
- have a significant psychiatric disorder
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Low Pulse Width (<500 μsec)
Spinal Cord Stimulation System will be programmed to pulse widths <500 μsec.
|
Algovita™ SCS-systemet er indiceret som en hjælp til håndtering af kroniske uhåndterlige smerter i krop og/eller lemmer, inklusive unilaterale eller bilaterale smerter forbundet med mislykket rygkirurgi, uhåndterlige lændesmerter og bensmerter.
|
Aktiv komparator: High Pulse Width (>1000 μsec)
Spinal Cord Stimulation System will be programmed to pulse widths >1000 μsec
|
Algovita™ SCS-systemet er indiceret som en hjælp til håndtering af kroniske uhåndterlige smerter i krop og/eller lemmer, inklusive unilaterale eller bilaterale smerter forbundet med mislykket rygkirurgi, uhåndterlige lændesmerter og bensmerter.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Effect of Pulse Widths on Pain Clinical Outcomes
Tidsramme: For 7 days following intervention
|
To evaluate the effect of conventional pulse widths <500 μsec and pulse widths >1000 μsec on clinical outcomes during temporary trial as measured by patient defined pain maps.
|
For 7 days following intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in Targeted Pain
Tidsramme: For 7 days following intervention
|
To evaluate the effect of conventional pulse widths <500μsecand pulse widths and >1000μsecon clinical outcomes during temporary trial as measured by the number of participants that reported significant change in targeted pain compared to baseline using the NRS at the end of the trial period.
|
For 7 days following intervention
|
Distribution of Paesthesia
Tidsramme: For 7 days following intervention
|
At end of each arm, subjects will be asked to complete a diagram that shows distribution of paresthesia.
|
For 7 days following intervention
|
Research Participant Program Preference
Tidsramme: For 7 days following intervention
|
At the end of the trial period, subjects will be asked to select their favorite program.
|
For 7 days following intervention
|
Quality of Pain Relief
Tidsramme: For 7 days following intervention
|
At the end of the trial period, subjects will be asked to rate the quality of the pain relief achieved during the trial (from either arm) using the following ordinal scale; Excellent, Very Good, Good, Fair or Poor
|
For 7 days following intervention
|
Research Participant Pain Relief Satisfaction
Tidsramme: For 7 days following intervention
|
At the end of the trial period, subjects will be asked to rate their overall satisfaction with the pain relief achieved during the trial (from either arm) using the following ordinal scale; Very Satisfied, Satisfied, Neither Satisfied nor Unsatisfied, Unsatisfied or Very Unsatisfied
|
For 7 days following intervention
|
≥ 50% Pain Relief
Tidsramme: For 7 days following intervention
|
Number of patients who achieved ≥ 50% pain relief during the trial (from either arm)
|
For 7 days following intervention
|
Rate of AEs
Tidsramme: For 7 days following intervention
|
Rate of device-related and/or procedure-related AEs from SCS implant through study completion or study exit.
|
For 7 days following intervention
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
27. november 2018
Primær færdiggørelse (Faktiske)
2. oktober 2019
Studieafslutning (Faktiske)
2. oktober 2019
Datoer for studieregistrering
Først indsendt
26. november 2018
Først indsendt, der opfyldte QC-kriterier
27. november 2018
Først opslået (Faktiske)
28. november 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
8. marts 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
15. februar 2021
Sidst verificeret
1. februar 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Expanded Long Pulse
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Smerte
-
Quiropraxia y EquilibrioUniversidad Nacional Andres BelloAfsluttetMyofascial Trigger Point Pain (MTrP)Chile
-
East Carolina UniversityTrukket tilbage
-
Quiropraxia y EquilibrioIkke rekrutterer endnuMyofascial Trigger Point Pain (MTrP)Chile
-
Wake Forest University Health SciencesRekruttering
-
Rijnstate HospitalSaluda Medical Pty LtdTilmelding efter invitationPolyneuropatier | Kronisk smertesyndrom | Multi Focal Pain | Mislykket nakkekirurgi syndromHolland
-
University of California, San DiegoJohns Hopkins University; United States Department of Defense; The Cleveland... og andre samarbejdspartnereTilmelding efter invitationKirurgisk amputation af nedre ekstremiteter | Post-amputation Phantom Limb PainForenede Stater
-
Brugmann University HospitalTrukket tilbagePhantom Limb Pain (PLP) | Primær/sekundær arhyperalgesiBelgien
-
Oslo University HospitalUniversity of Oslo; Fysiofondet; Oslo Metropolitan UniversityRekrutteringGluteal tendinopati | Trochanterisk bursitis | Lateral hoftesmerter | GTPS - Greater Trochanteric Pain SyndromeNorge
-
Pôle Saint HélierRekruttering
-
Guna S.p.aAfsluttetStørre trochanterisk smertesyndrom | Pertrokantær fraktur | Gluteal tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Senelidelse | Gluteal musklerItalien
Kliniske forsøg med Algovita rygmarvsstimuleringssystem
-
The Cleveland ClinicAfsluttetKompleks regionalt smertesyndromForenede Stater
-
University of MinnesotaIkke rekrutterer endnuCervikal rygmarvsskade
-
SGX Procura LLCAfsluttetSmerte | Øvre lemForenede Stater
-
Boston Scientific CorporationAfsluttetSmerte | Neuropatisk smerteForenede Stater
-
Nevro CorpAfsluttet
-
Stanford UniversityIkke rekrutterer endnu
-
The Cleveland ClinicAktiv, ikke rekrutterende
-
Thomas Jefferson UniversityTim ReynoldsTilmelding efter invitationRygmarvssygdomme | RygmarvsskaderForenede Stater
-
University of ManitobaRekrutteringRygmarvsskader | Rygmarvsskade på C5-C7 niveau | Paraplegi, Spinal | Paraplegi, ufuldstændigCanada